GALECTIN THERAPEUTICS INC's ticker is GALT and the CUSIP is 363225202. A total of 79 filers reported holding GALECTIN THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 1.95 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $518,930 | +34.5% | 229,615 | +42.2% | 0.00% | – |
Q1 2024 | $385,842 | +44.0% | 161,440 | 0.0% | 0.00% | – |
Q4 2023 | $267,990 | -13.5% | 161,440 | 0.0% | 0.00% | – |
Q3 2023 | $309,965 | +33.3% | 161,440 | 0.0% | 0.00% | – |
Q2 2023 | $232,474 | -36.3% | 161,440 | -7.1% | 0.00% | – |
Q1 2023 | $364,854 | -7.1% | 173,740 | -50.0% | 0.00% | – |
Q4 2022 | $392,652 | +38.7% | 347,480 | +100.0% | 0.00% | – |
Q3 2022 | $283,000 | +24.1% | 173,740 | 0.0% | 0.00% | – |
Q2 2022 | $228,000 | -18.6% | 173,740 | 0.0% | 0.00% | – |
Q1 2022 | $280,000 | -14.9% | 173,740 | +9.4% | 0.00% | – |
Q4 2021 | $329,000 | -46.6% | 158,759 | 0.0% | 0.00% | – |
Q3 2021 | $616,000 | +21.3% | 158,759 | 0.0% | 0.00% | – |
Q2 2021 | $508,000 | -61.9% | 158,759 | -74.2% | 0.00% | – |
Q1 2021 | $1,335,000 | -11.2% | 614,994 | -8.4% | 0.00% | – |
Q4 2020 | $1,504,000 | -19.3% | 671,394 | -3.8% | 0.00% | – |
Q3 2020 | $1,864,000 | -11.5% | 698,113 | +1.5% | 0.00% | – |
Q2 2020 | $2,106,000 | +61.9% | 688,083 | +3.7% | 0.00% | – |
Q1 2020 | $1,301,000 | -32.2% | 663,783 | -1.1% | 0.00% | – |
Q4 2019 | $1,919,000 | -6.0% | 671,117 | +20.7% | 0.00% | – |
Q3 2019 | $2,041,000 | -4.6% | 556,124 | +7.9% | 0.00% | – |
Q2 2019 | $2,140,000 | +325.4% | 515,546 | +423.9% | 0.00% | – |
Q1 2019 | $503,000 | +50.1% | 98,403 | +0.9% | 0.00% | – |
Q4 2018 | $335,000 | +28.4% | 97,558 | +124.9% | 0.00% | – |
Q3 2018 | $261,000 | -13.9% | 43,378 | -8.8% | 0.00% | – |
Q2 2018 | $303,000 | +265.1% | 47,550 | +172.5% | 0.00% | – |
Q1 2018 | $83,000 | +219.2% | 17,450 | +52.4% | 0.00% | – |
Q3 2017 | $26,000 | -7.1% | 11,450 | 0.0% | 0.00% | – |
Q2 2017 | $28,000 | +3.7% | 11,450 | 0.0% | 0.00% | – |
Q1 2017 | $27,000 | +145.5% | 11,450 | 0.0% | 0.00% | – |
Q4 2016 | $11,000 | -15.4% | 11,450 | 0.0% | 0.00% | – |
Q3 2016 | $13,000 | -23.5% | 11,450 | -3.0% | 0.00% | – |
Q2 2016 | $17,000 | 0.0% | 11,809 | 0.0% | 0.00% | – |
Q1 2016 | $17,000 | -5.6% | 11,809 | 0.0% | 0.00% | – |
Q4 2015 | $18,000 | -35.7% | 11,809 | 0.0% | 0.00% | – |
Q3 2015 | $28,000 | -15.2% | 11,809 | 0.0% | 0.00% | – |
Q2 2015 | $33,000 | -95.2% | 11,809 | -94.2% | 0.00% | – |
Q1 2015 | $686,000 | +0.7% | 204,416 | +3.9% | 0.00% | – |
Q4 2014 | $681,000 | -22.5% | 196,700 | +13.1% | 0.00% | – |
Q3 2014 | $879,000 | -62.6% | 173,967 | +2.2% | 0.00% | – |
Q2 2014 | $2,350,000 | – | 170,229 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Benchmark Capital Advisors | 221,700 | $1,051,000 | 0.83% |
EAM Global Investors LLC | 227,063 | $1,076,000 | 0.56% |
EAM Investors, LLC | 319,187 | $1,513,000 | 0.25% |
COURAGE CAPITAL MANAGEMENT LLC | 30,000 | $142,000 | 0.11% |
Cutter & CO Brokerage, Inc. | 53,600 | $254,000 | 0.10% |
SABBY MANAGEMENT, LLC | 286,800 | $1,360,000 | 0.08% |
D.A. DAVIDSON & CO. | 731,300 | $3,466,000 | 0.07% |
Tibra Equities Europe Ltd | 63,414 | $301,000 | 0.05% |
Advisor Group, Inc. | 556,377 | $2,637,000 | 0.04% |
Laurel Wealth Advisors, Inc. | 21,400 | $101,000 | 0.03% |